欢迎来到范德生物BIOFOUNT
范德生物中国

中文范德生物中文语言

范德生物产品购买购物车
0
搜索
Linogliride_75358-37-1_产品详情
75358-37-1
  • names:

    (E)-N-((E)-1-methylpyrrolidin-2-ylidene)-N'-phenylmorpholine-4-carboximidamide

  • CAS号:

    75358-37-1

    MDL Number:
  • MF(分子式): C16H22N4O MW(分子量): 286.37
  • EINECS: Reaxys Number:
  • Pubchem ID: Brand:BIOFOUNT
Linogliride
货品编码 规格 纯度 价格 (¥) 现价(¥) 特价(¥) 库存描述 数量 总计 (¥)
快速询价
收起
你想询价的产品
请准确填写您的联系方式,以便为您提供最好的服务。
中文别名 Linogliride
英文别名 Linogliride; McN 3935; McN-3935; McN3935; Linogliridum; Linoglirida;
CAS号 75358-37-1
Inchi InChI=1S/C16H22N4O/c1-19-9-5-8-15(19)18-16(20-10-12-21-13-11-20)17-14-6-3-2-4-7-14/h2-4,6-7H,5,8-13H2,1H3/b17-16-,18-15+
InchiKey OPPLDIXFHYTSSR-YQFKSOGVSA-N
分子式 Formula C16H22N4O
分子量 Molecular Weight 286.37
溶解度Solubility
性状 Solid powder
储藏条件 Storage conditions Dry, dark and store at 0-4℃ for short term (days to weeks) or -20℃ for long term (Store correctly 2-3years).
产品说明 Linogliride(CAS:75358-37-1):仅限应用于工业或者科学研究过程中非医疗目的,不应用于人类或动物的临床诊断以及治过程疗,该产品非药用,非食用。
IntroductionLinogliride is an antidiabetic agent.
Application1
Application2
Application3
警示图
危险性 Warning
危险性警示
安全声明
安全防护
备注
[1]Levin PA, Jovanovic L, Chalew SA, Martin L, Pitarra DK, Kim F, Kowarski AA. Linogliride fumarate, representing a new class of oral hypoglycemic agent for diabetes. Clin Pharmacol Ther. 1987 Nov;42(5):498-503. PubMed PMID: 3315390.
[2]Ronner P, Cheong E, Khalid P, Tuman RW, Matschinsky FM. Effect of linogliride on hormone release from perfused rat pancreas. Fuel dependence and desensitization by tolbutamide. Diabetes. 1991 Jul;40(7):878-84. PubMed PMID: 2060724.
[3] Ronner P, Higgins TJ, Kimmich GA. Inhibition of ATP-sensitive K+ channels in pancreatic beta-cells by nonsulfonylurea drug linogliride. Diabetes. 1991 Jul;40(7):885-92. PubMed PMID: 2060725.
[4] Zawalich WS, Rasmussen G, Tuman RW, Tutwiler GF. Influence of the oral hypoglycemic agent linogliride (McN-3935) on insulin secretion from isolated rat islets of Langerhans. Endocrinology. 1987 Mar;120(3):880-5. PubMed PMID: 3542516.
[5] Wu WN, Mutter MS. Biotransformation of linogliride, a hypoglycemic agent in laboratory animals and humans. J Pharm Biomed Anal. 1995 Jun;13(7):857-67. PubMed PMID: 8562609.
6: Salhanick AI, Leighty SJ, Amatruda JM. Postreceptor regulation of insulin action in primary cultures of rat hepatocytes by oral hypoglycemic agents: effects of linogliride and chlorpropamide. Horm Metab Res. 1989 Nov;21(11):596-601. PubMed PMID: 2687145.7: Ng KT, Holland ML, Plutte JA. Determination of linogliride in biological fluids by high-performance liquid chromatography. J Chromatogr. 1984 Nov 28;311(2):418-23. PubMed PMID: 6520190.8: Chrzanowski FA, Ahmad K. The preparation and evaluation of salt forms of linogliride with reduced solubilities as candidates for extended release. Drug Dev Ind Pharm. 2017 Mar;43(3):421-431. doi: 10.1080/03639045.2016.1257019. Epub 2016 Nov 21. PubMed PMID: 27808569.9: Woodfork KA, Wonderlin WF, Peterson VA, Strobl JS. Inhibition of ATP-sensitive potassium channels causes reversible cell-cycle arrest of human breast cancer cells in tissue culture. J Cell Physiol. 1995 Feb;162(2):163-71. PubMed PMID: 7822427.10: Klimatcheva E, Wonderlin WF. An ATP-sensitive K(+) current that regulates progression through early G1 phase of the cell cycle in MCF-7 human breast cancer cells. J Membr Biol. 1999 Sep 1;171(1):35-46. PubMed PMID: 10485992.1
    对不起,暂无产品评价!
MSDS
SDS 1.0 中文
展开
SDS 1.0 英文
展开
        新闻
        抱歉,暂无数据!
        My title page contents